# KESIMPTA

NDC: 0078-1007
Generic name: ofatumumab
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20091026

FDA application: BLA125326

## Active ingredients

- OFATUMUMAB: 20 mg/.4mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-1007"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-1007
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6a8a3f53-2062-48ff-9dbe-b939df133ca3